Fig. 1 · Structure

Documents & Downloads

DMOG

Cat. No. A13998 CAS 89464-63-1

HIF-PH inhibitor

DMOG is a cell permeable, competitive inhibitor of HIF-PH. It acts to stabilize HIF-1α expression at normal oxygen tensions in cultured cells, at concentrations between 0.1 and 1 mM.

In Stock

Publications for DMOG

1 publication citing this product

  1. Hideaki Nakamura, .et al. , PLoS One, 2018, 13(2): e0192136 PMID: 29466367

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
HIF prolyl hydroxylase

DMOG Research Summary

This section summarizes 3 in vitro studies and 1 in vivo study of DMOG from 3 published references. In vitro models include ARPE-19 cells; human BMSCs. In vivo models include 10-week-old C57BL/6 mice.

DMOG In Vitro Studies

In ARPE-19 cells, DMOG at 0.5 mM and DMOG + SI co-treatment upregulated SOD2 expression compared with controls. In studies using human BMSCs treated with DMOG at 1000 μM for 48 h, no significant differences in marker expression were observed between MSC-Exos and DMOG-MSC-Exos. TEM analysis showed no obvious differences in morphology and quantity between these groups. [1,2]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

SOD2 transcript expression in ARPE-19 cells

Cell-based study · ARPE-19 cells [1]

In ARPE-19 cells treated with DMOG at 0.5 mM, SOD2 expression was upregulated by DMOG and DMOG + SI co-treatment compared with controls.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
SOD2 transcript levelsReported result SOD2 expression was upregulated by DMOG and DMOG + SI co-treatment compared to controls[1]

Literature-Reported Treatment Conditions

Treatment concentration
0.5 mM
Vehicle
DMEM/F12
Reported limits
Not stated in the sentences used: route, schedule.
Methods and source locations

Compound reported in the paper: DMOG

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Material and methods > Cell culture (S7); Results > HIF stabilization aggravates oxidative damage (S73); Results > SOD activity paradoxically contributed to cell death (S113, S114)

SOD2 transcript levels: SOD2 transcript levels; comparator: controls — Results > SOD activity paradoxically contributed to cell death (S113, S114)

Marker expression in BMSC exosome groups

Cell-based study · Human BMSCs [2]

Human BMSCs were treated with DMOG at 1000 μM for 48 h under culture conditions. No significant differences in marker expression were observed between the MSC-Exos and DMOG-MSC-Exos groups.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
expression of these markersReported result no significant differences were observed on the expression of these markers between the MSC-Exos and DMOG-MSC-Exos groups[2]

Literature-Reported Treatment Conditions

Treatment concentration
1000 μM
Exposure duration
for 48 h
Method
under culture conditions
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: DMOG

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Methods > Cell culture (S1, S3); Results > Exosome isolation, characterization, and internalization (S67)

expression of these markers: expression of these markers; comparator: MSC-Exos — Results > Exosome isolation, characterization, and internalization (S67)

TEM assessment of BMSC exosome morphology and quantity

Cell-based study · Human BMSCs [2]

Human BMSCs were treated with DMOG at 1000 μM for 48 h under culture conditions. TEM analysis showed no obvious differences in morphology and quantity between the MSC-Exos and DMOG-MSC-Exos groups.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
TEM analysisReported result no obvious differences in morphology and quantity between the MSC-Exos and DMOG-MSC-Exos groups[2]

Literature-Reported Treatment Conditions

Treatment concentration
1000 μM
Exposure duration
for 48 h
Method
under culture conditions
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: DMOG

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Methods > Cell culture (S1, S3); Results > Exosome isolation, characterization, and internalization (S68)

TEM analysis: TEM analysis; comparator: MSC-Exos — Results > Exosome isolation, characterization, and internalization (S68)

DMOG In Vivo Studies

Following surgical destabilization of the medial meniscus in mice, DMOG was administered by intraperitoneal injection at 25 mg/kg per day. At 8 weeks post-OA surgery, OARSI scores declined in the DMM+DMOG group and rose in the DMM group. [3]

OARSI scores following medial meniscus destabilization

Animal study · 10-week-old C57BL/6 mice [3]

In mice following surgical destabilization of the medial meniscus, DMOG was administered by intraperitoneal injection at 25 mg/kg per day. At 8 weeks post-OA surgery, OARSI scores declined in the DMM+DMOG group and rose in the DMM group.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
OARSI scoreReported result OARSI score was declined by DMOG, and rising in DMM group[3]

Conditions shared by the study groups

Route
intraperitoneal (i.p.) injection
Treatment course
per day; 8 weeks post-OA surgery
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
DMOG 25 mg/kg per dayDMM groupOARSI score was declined by DMOG, and rising in DMM group[3]
DMOG 25 mg/kg per day
Model: 10-week-old C57BL/6 mice
Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: DMOG

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Results > DMOG ameliorated OA development in DMM mouse model (S71); Materials and methods > Animal model (S149, S150, S151, S152)

OARSI score: OARSI score; comparator: DMM group — Results > DMOG ameliorated OA development in DMM mouse model (S71)

DMOG 25 mg/kg per day · Results > DMOG ameliorated OA development in DMM mouse model (S71); Materials and methods > Animal model (S151, S152)

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 89464-63-1
Applications HIF-PH inhibitor
Formula C6H9NO5
Molecular Weight 175.14
Synonyms Dimethyloxaloyl glycine
SMILES
COC(=O)CNC(=O)C(=O)OC

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 33 mg/mL (188.42 mM)
Water 33 mg/mL (188.42 mM)
Ethanol 33 mg/mL

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

DMOG Research References

  1. [1] Henning Y, Blind US, Larafa S, et al. Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction. Cell Death Dis (2022). PMID: 35906211 DOI: 10.1038/s41419-022-05121-z Source material
  2. [2] Liang B, Liang JM, Ding JN, et al. Dimethyloxaloylglycine-stimulated human bone marrow mesenchymal stem cell-derived exosomes enhance bone regeneration through angiogenesis by targeting the AKT/mTOR pathway. Stem Cell Res Ther (2019). PMID: 31747933 DOI: 10.1186/s13287-019-1410-y Source material
  3. [3] Hu S, Zhang C, Ni L, et al. Stabilization of HIF-1α alleviates osteoarthritis via enhancing mitophagy. Cell Death Dis (2020). PMID: 32587244 DOI: 10.1038/s41419-020-2680-0 Source material

Publications

1 publication citing this product

  1. Hideaki Nakamura, .et al. , PLoS One, 2018, 13(2): e0192136 PMID: 29466367

Added to your cart

View Cart Checkout
Loading...